Observational Cohort Study of Lasmiditan Exposure and Motor Vehicle Accidents in the United States (MI DRIVE) H8H-MC-B006

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Other
• If ‘other’, further details on the scope of the study:
  Safety in operating heavy machinery
• Data collection methods:
  Primary data collection

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Medicinal product name:
  RAYVOW
• Study drug International non-proprietary name (INN) or common name:
  LASMIDITAN
• Anatomical Therapeutic Chemical (ATC) code:
  (N02CC08) lasmiditan

  lasmiditan
• Medical condition to be studied:
  Migraine

Population studied

No information provided.

Study design details

No information provided.